Founded in 2001, Takeda Ventures invests in early-stage companies and provides support and guidance to entrepreneurs driving concepts through clinical proof of concept. They aim to create synergies with Takeda's R&D resources and build a portfolio of strategic investments, with a focus on oncology, gastroenterology, neuroscience, and rare diseases.